Journal article
Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi
American journal of cardiovascular drugs : drugs, devices, and other interventions, Vol.22(3), pp.231-238
05/01/2022
DOI: 10.1007/s40256-021-00509-2
PMID: 34738217
Abstract
Left ventricular thrombi form due to the presence of Virchow's triad in patients with left ventricular systolic dysfunction. This complication increases the incidence of systemic embolization, hence anticoagulation is recommended to decrease this risk. Up to the present time, vitamin K antagonists are recommended by all societal guidelines for patients with left ventricular thrombi. Recently, several studies have investigated the role of different anticoagulants and yielded promising outcomes. This opinion article focuses on the evidence supporting vitamin K antagonists and direct oral anticoagulants in patients with left ventricular thrombi.
Details
- Title: Subtitle
- Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi
- Creators
- Yehia Saleh - Houston MethodistAbdullah Al-Abcha - Michigan State UniversityOla Abdelkarim - Houston MethodistMahmoud Abdelnabi - Alexandria UniversityAbdallah Almaghraby - Alexandria UniversityNeal S Kleiman - Houston Methodist
- Resource Type
- Journal article
- Publication Details
- American journal of cardiovascular drugs : drugs, devices, and other interventions, Vol.22(3), pp.231-238
- DOI
- 10.1007/s40256-021-00509-2
- PMID
- 34738217
- ISSN
- 1175-3277
- eISSN
- 1179-187X
- Language
- English
- Date published
- 05/01/2022
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984756261702771
Metrics
5 Record Views